KALA BIO Executes 1-for-50 Reverse Stock Split, Advances AI Platform

KALA BIO (NASDAQ: KALA), a clinical-stage biopharmaceutical company with a unique focus on AI infrastructure for biotech, has executed a 1-for-50 reverse stock split of its common stock. The reverse split became effective at 4:05 p.m. on May 8, 2026, and split-adjusted trading begins on the Nasdaq Capital Market at the open on May 11, 2026. This corporate action reduces KALA's outstanding common shares from approximately 929.5 million to 18.6 million. Cash payments will be issued for fractional shares, and proportional adjustments are made to outstanding equity awards, warrants, and other convertible securities. The reverse split is a strategic move to potentially increase the stock's price per share, often aimed at meeting exchange listing requirements or attracting institutional investors.

Beyond the financial restructuring, KALA BIO is advancing an innovative dual strategy. The company is building a proprietary biologics pipeline, including its mesenchymal stem cell secretome (MSC-S) platform and FDA Orphan Drug- and Fast Track-designated product candidates. Simultaneously, KALA is developing a scalable AI platform-as-a-service business, designed to deploy secure, purpose-built AI solutions directly within biotech and pharmaceutical client environments. Through an exclusive worldwide license for the Researgency AI research platform from Younet, KALA aims to serve as the dedicated AI infrastructure partner for the biotechnology industry. The platform, Researgency.ai, enables organizations to unlock the value of their proprietary biological data without surrendering control. KALA is focusing on enterprise security, real-time performance, and seamless integration, positioning itself at the forefront of the life sciences AI sector.

InvestorWire (IW), a specialized communications platform, distributed the press release. IW is part of the Dynamic Brand Portfolio @ IBN, offering services such as press release syndication, editorial syndication to 5,000+ outlets, and social media distribution. For more details, visit the full press release at https://ibn.fm/yUznR. KALA's reverse stock split and its AI infrastructure platform highlight the company's efforts to stabilize its financial structure while pursuing cutting-edge technology innovation in biotechnology.